[Characteristics of the course of viral hepatitis B in patients with concomitant diseases treated with glucocorticosteroids].
D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001327:Autoimmune Diseases / Q000188:drug therapy*; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy / Q000201:enzymology; D002648:Child; D002675:Child, Preschool; D005938:Glucocorticoids / Q000627:therapeutic use*; D006509:Hepatitis B / Q000150:complications / Q000503:physiopathology*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D008875:Middle Aged; D011763:Pyrrolizidine Alkaloids / Q000633:toxicity; D051381:Rats
D005938:Glucocorticoids; D011763:Pyrrolizidine Alkaloids; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; C010178:heliotrine
Osobennosti techneiia virusnogo gepatitia B u bol'nykh s soputstvuiushchimi zabolevaniiami, lechennykh gliukokortikosteroidami.